Falco Reissig

Carl Eschebach Str. 7
Radeberg, SN 01454, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer.

Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer.

Journal: Molecular pharmaceutics
Published: May 27, 2026

First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin.

First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 16, 2026

Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair.

Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair.

Journal: European journal of nuclear medicine and molecular imaging
Published: October 25, 2025

It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

Journal: EJNMMI radiopharmacy and chemistry
Published: April 22, 2025

PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression.

PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 10, 2025

Preparation of Macrobicyclic Cryptands for Radiometal Complexation: Preparation of Macropa-Based Cryptands for Efficient Complexation of Radiometals.

Preparation of Macrobicyclic Cryptands for Radiometal Complexation: Preparation of Macropa-Based Cryptands for Efficient Complexation of Radiometals.

Journal: Journal of labelled compounds & radiopharmaceuticals
Published: December 20, 2024

Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In.

Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In.

Journal: Bioconjugate chemistry
Published: August 26, 2024

The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics.

The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics.

Journal: RSC medicinal chemistry
Published: January 26, 2024

Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis.

Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 27, 2023

Equilibrium Thermodynamics of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical Interest.

Equilibrium Thermodynamics of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical Interest.

Journal: Inorganic chemistry
Published: September 13, 2023

Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu Reaction.

Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu Reaction.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 26, 2023

Efficient Production of the PET Radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy Using the 134Ba(p,2n)133La Reaction.

Efficient Production of the PET Radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy Using the 134Ba(p,2n)133La Reaction.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 07, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026